Amy DuRoss, based in United States, is currently a President, Cell and Gene Therapies at CSafe Global, bringing experience from previous roles at Frazier Healthcare Partners, Synapticure Inc., BioLife Solutions, Inc. and ARM Foundation for Cell & Gene Medicine. Amy DuRoss holds a 2022 - 2022 Corporate Board Governance Certificate @ UCLA Anderson School of Management. With a robust skill set that includes Strategy, Business Development, Business Strategy, Leadership, Biotechnology and more, Amy DuRoss contributes valuable insights to the industry. Amy DuRoss has 2 emails and 2 mobile phone numbers on RocketReach.